H2BC12L and colonic neoplasm: Another interesting avenue is the synergistic combination of sulforaphane with the BET inhibitor JQ1 in colon cancer models, targeting the non-histone protein Cell cycle and apoptosis regulator 2 (CCAR2) for acetylation and altered Wnt coactivator functionality [165].